ARTICLE | Company News
BZL Biologics LLC, ImaginAb deal
June 18, 2012 7:00 AM UTC
The companies added the co-development of a companion imaging agent to a 2009 deal granting ImaginAb a sublicense to BZL's huJ591 mAb. ImaginAb will provide clinical companion diagnostic capabilities ...